Title: Senior Science Fellow
Company: Center for Arms Control and Non-Proliferation
Location: Gloucester, Massachusetts, United States
Lynn Klotz, Senior Science Fellow at Center for Arms Control and Non-Proliferation, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in physical biochemistry instruction and biosecurity activism.
After obtaining a Bachelor of Arts in mathematics from Princeton University in New Jersey in 1965, Dr. Klotz subsequently earned a PhD in chemistry from the University of California San Diego in 1971. He provided superior education as an assistant and associate professor of biochemistry and molecular biology from 1971 to 1979 with Harvard University and visiting associate professor of biochemical sciences with Princeton University from 1979 to 1981. Dr. Klotz served with Biotechnica International as vice president of scientific planning and new business development from 1981 to 1989. In the late 1990s, he led a three-year joint effort between the Federation of American Scientists Working Group and the pharmaceutical industry association, PhRMA, to address BWC verification protocol negotiations so as to alleviate industry concerns. While at Harvard, he was a recipient of the prestigious Dreyfus Teacher-Scholar grant for teaching excellence.
Since 2003, Dr. Klotz has been a member of Scientists Working Group on Biological and Chemical Weapons Security and since 2005 he served as a senior science fellow with the Center for Arms Control and Non-Proliferation, a nonpartisan nonprofit dedicated to reducing and eventually eliminating the threats posed by nuclear, chemical and biological weapons through Congressional engagement and public education. In 1983, he co-authored “The Gene Age: Genetic Engineering and the Next Industrial Revolution,” for which he was nominated for a Pulitzer Prize, and has contributed over 100 articles to professional journals. He has subsequently authored “Breeding Bio Insecurity: How U.S. Biodefense is Exporting Fear, Globalizing Risk, and Making Us All Less Secure” for The University of Chicago Press in 2009, which was picked by the publisher among its Best Books of 2009 in The Atlantic. In 2022, he penned “Beyond The Science: The Business of Drug Development,” which is currently available on Amazon. As a career highlight, he cites his recommendation to a faculty position at Harvard University directly after receiving his PhD at University of California San Diego.
Contact Dr. Klotz: